Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 11, 2011, Pages 2501-2508

  Croxall, Gemma ^a   Hale, James ^b   Weston, Vivienne ^c   Manning, Georgina ^a   Cheetham, Phil ^a   Achtman, Mark ^b   Mcnally, Alan ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

ExPEC; MLST; UTIs

Indexed keywords

AMPICILLIN; CEFRADINE; CIPROFLOXACIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HOSPITAL CARE; HUMAN; MALE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CELL LINE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 80054685465     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr349     Document Type: Article

References (23)

1. Plowman R, Graves N, Griffin MA et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001; 47: 198-209.
2. Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extendedspectrum b-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-43.
3. Cove-Smith A, Almond M. Management of urinary tract infections in the elderly. Trends Urol Gynaecol Sex Health 2007; 12: 31-4.
4. Yamamoto S. Molecular epidemiology of uropathogenic Escherichia coli. J Infect Chemother 2007; 13: 68-73.
5. Brzuszkiewicz E, Bruggemann H, Liesegang H et al. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 2006; 103: 12879-84.
6. Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 2005; 295: 383-404.
7. Dhanji H, Doumith M, Rooney PJ et al. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum b-lactamases in nursing homes in Belfast, UK. J Antimicrob Chemother 2011; 66: 297-303.
8. Wirth T, Falush D, Lan R et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006; 60: 1136-51.
9. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66: 1-14.
10. Clermont O, Lavollay M, Vimont S et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008; 61: 1024-8.
11. Lau SH, Kaufmann ME, Livermore DM et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 b-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008; 62: 1241-4.
12. Pitout JDD, Nordmann P, Laupland KB et al. Emergence of Enterobacteriaceae producing extended-spectrum b-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-9.
13. Croxall G, Weston V, Joseph S et al. Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J Med Microbiol 2011; 60: 102-9.
14. Andrews J. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009; 64: 454-89.
15. Fang H, Ataker F, Hedin G et al. Molecular epidemiology of extended-spectrum b-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 2008; 46: 707-12.
16. Cao V, Lambert T, Nhu DQ et al. Distribution of extended-spectrum b-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 2002; 46: 3739-43.
17. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-72.
18. Rooney PJ, O'Leary MC, Loughrey AC et al. Nursing homes as a reservoir of extended-spectrum b-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009; 64: 635-41.
19. Nicolas-Chanoine M, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
20. Peirano G, Richardson D, Nigrin J et al. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extendedspectrum-β-lactamase-producing Escherichia coli isolates from Canada. Antimicrob Agents Chemother 2010; 54: 1327-30.
21. Johnson JR, Johnston B, Clabots C et al. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010; 51: 286-94.
22. JohnsonJR, Miller S, Johnston B et al. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and catswithin a household. J Clin Microbiol 2009; 47: 3721-5.
23. Coelho A, Mora A, Mamani R et al. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 2011; 66: 517-26.